Zylox-Tonbridge Receives Marketing Approvals for Multiple Vascular Devices in the UAE

Hangzhou, China-based Zylox-Tonbridge has received marketing approvals from the Ministry of Health and Prevention in the United Arab Emirates for five of its advanced products, including the ZENFluxion™ Drug-coated PTA Balloon Catheter, ZENFlow™ HP PTA Balloon Catheter, ZENFlow™ PTA Balloon Catheter, ZENFlex™ Peripheral Stent System, and ZENFLEX Pro™ Peripheral Drug-eluting Stent System.

This milestone marks Zylox-Tonbridge’s first approval in the Gulf region and demonstrates its commitment to expanding its market presence in the Middle East and advancing its global business initiatives.

Zylox-Tonbridge has experienced rapid international growth as a provider of innovative medical solutions. With a comprehensive product portfolio focused on peripheral vascular and neurovascular interventions, the company is committed to delivering breakthrough products and total healthcare solutions worldwide. Its products are currently available in more than 20 countries and regions and are widely recognized for their innovative designs and high quality.

The Middle East has emerged as a pivotal overseas market for Chinese medical device companies and Zylox-Tonbridge consistently showcases its offerings at events like the Arab Health Exhibition to strengthen its position in both regional and global markets. With the establishment of its warehouse and logistics center in Italy, the company aims to better serve healthcare providers and patients across Europe, the Middle East, and Africa.

en_GBEnglish (UK)